Jones, Gemma N.
Rooney, Claire
Griffin, Nicola
Roudier, Martine
Young, Lucy A.
Garcia-Trinidad, Antonio
Hughes, Gareth D.
Whiteaker, Jeffrey R.
Wilson, Zena
Odedra, Rajesh
Zhao, Lei
Ivey, Richard G.
Howat, William J.
Harrington, Elizabeth A.
Barrett, J. Carl
Ramos-Montoya, Antonio
Lau, Alan
Paulovich, Amanda G.
Cadogan, Elaine B.
Pierce, Andrew J.
Article History
Received: 23 March 2018
Revised: 17 August 2018
Accepted: 11 September 2018
First Online: 2 November 2018
<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate
: All samples were commercially acquired. AstraZeneca has a governance framework and processes in place to ensure that commercial sources have appropriate patient consent and ethical approval in place for collection of the samples for research purposes including use by for-profit companies. The AstraZeneca Biobank in the UK is licensed by the Human Tissue Authority (Licence No. 12109) and has National Research Ethics Service Committee (NREC) Approval as a Research Tissue Bank (RTB) (REC No 17/NW/0207) which covers the use of the samples for this project.
: The authors declare no competing interests.